http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35434338

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2192-2659
2192-2640
issueIdentifier 6
pageRange e2202467-
publicationName Advanced Healthcare Materials
startingPage e2202467
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3dd886da86c01f3132a7c371d82dd590
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d74d8b58080c8e4d52ac61a54e829bfe
bibliographicCitation Li X, Jiang C, Jia X, Cao Y, Mao Y, Hao JN, Yang Y, Zhang P, Li Y. Dual \"Unlocking\" Strategy to Overcome Inefficient Nanomedicine Delivery and Tumor Hypoxia for Enhanced Photodynamic-Immunotherapy. Adv Healthc Mater. 2023 Jan;12(6):e2202467. doi: 10.1002/adhm.202202467. PMID: 36377480.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac8c841bb31edabb397ce3f304ff7ea4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_217e02c577fb3d9abde89beb4cff1bd0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47d3923401ddeb8be3b378d893285765
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2649287567148a91e27a918cae96e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbe4f5de739055499566fef1af9a6f48
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5621-9528
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efd4cd8cc20812abecbaa8cf467f454d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4528cc0b90529ffd78cc9429eb324637
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date 2022-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/adhm.202202467
https://pubmed.ncbi.nlm.nih.gov/36377480
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40077
https://portal.issn.org/resource/ISSN/2192-2640
https://portal.issn.org/resource/ISSN/2192-2659
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Dual “Unlocking” Strategy to Overcome Inefficient Nanomedicine Delivery and Tumor Hypoxia for Enhanced Photodynamic‐Immunotherapy
discusses http://id.nlm.nih.gov/mesh/M0174272
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D010778
http://id.nlm.nih.gov/mesh/D053758
hasSubjectTerm http://id.nlm.nih.gov/mesh/D059016
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D050997
http://id.nlm.nih.gov/mesh/D000072258
http://id.nlm.nih.gov/mesh/D007167
http://id.nlm.nih.gov/mesh/D000860Q000188
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d4cb671d20806caaf5644afb03f6746
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72

Total number of triples: 47.